よむ、つかう、まなぶ。
05資料2-1森野委員提出資料（RSウイルス母子免疫ワクチンと抗体製剤ファクトシート） (54 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
(RSV): Australian Immunization Handbook. 2025/07/31.
https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/respiratorysyncytial-virus-rsv (accessed 2025/10/06).
158.
Kim HJ, Choi S, Choe YJ. RSV Prevention Strategies in Korean Children: A Review of Current
Approaches and Emerging Options. Infect Chemother 2025; 57(1): 31-7.
159.
World Health Organization. WHO Prequalification. https://extranet.who.int/prequal/ (accessed
2025/10/06).
160.
US Centers for Disease Control and Prevention. RSV Immunization Guidance for Infants and
Young Children. 2025/08/18. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-youngchildren.html (accessed 2025/10/06).
161.
UK Health Security Agency. Respiratory syncytial virus (RSV) vaccination programme.
2025/08/27. https://www.gov.uk/government/collections/respiratory-syncytial-virus-rsv-vaccinationprogramme (accessed 2025/10/06).
162.
UK Health Security Agency. Respiratory syncytial virus: the green book, chapter 27a.
2025/07/16. https://www.gov.uk/government/publications/respiratory-syncytial-virus-the-green-bookchapter-27a (accessed 2025/10/06).
163.
Haute Autorité de Santé（フランス高等保健機構）. BEYFORTUS (nirsévimab) - Virus
respiratoire syncytial（フランス語より機械翻訳：BEYFORTUS (nirsevimab) - Respiratory syncytial
virus）. 2024/11/20. https://www.has-sante.fr/jcms/p_3556743/fr/beyfortus-nirsevimab-virus-respiratoiresyncytial (accessed 2025/10/06).
164.
Robert Koch Institut. Empfehlung zur RSV-Prophylaxe, Zielgruppe（ドイツ語より機械翻訳：
Recommendation for RSV prophylaxis, target group）. 2025/05/09.
https://www.rki.de/SharedDocs/FAQs/DE/Impfen/RSVProphylaxe/Empfehlung/FAQ_Liste_Empfehlung.html#entry_16918894 (accessed 2025/10/06).
165.
Robert Koch Institut. Epidemiologisches Bulletin - Recommendations by the Standing
Committee on Vaccination (STIKO) at the Robert Koch Institute – 2025. 2025/02/04.
https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKOrecommendations/Downloads/04_25_english.pdf (accessed 2025/10/06).
166.
Korea Ministry of Food and Drug Safety. 베이포투스주(니르세비맙)（韓国語より機械翻訳：
Beyfortus(nirsevimab)）. 2024/04/30. https://nedrug.mfds.go.kr/searchDrug (accessed 2025/10/06).
54
https://immunisationhandbook.health.gov.au/contents/vaccine-preventable-diseases/respiratorysyncytial-virus-rsv (accessed 2025/10/06).
158.
Kim HJ, Choi S, Choe YJ. RSV Prevention Strategies in Korean Children: A Review of Current
Approaches and Emerging Options. Infect Chemother 2025; 57(1): 31-7.
159.
World Health Organization. WHO Prequalification. https://extranet.who.int/prequal/ (accessed
2025/10/06).
160.
US Centers for Disease Control and Prevention. RSV Immunization Guidance for Infants and
Young Children. 2025/08/18. https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/infants-youngchildren.html (accessed 2025/10/06).
161.
UK Health Security Agency. Respiratory syncytial virus (RSV) vaccination programme.
2025/08/27. https://www.gov.uk/government/collections/respiratory-syncytial-virus-rsv-vaccinationprogramme (accessed 2025/10/06).
162.
UK Health Security Agency. Respiratory syncytial virus: the green book, chapter 27a.
2025/07/16. https://www.gov.uk/government/publications/respiratory-syncytial-virus-the-green-bookchapter-27a (accessed 2025/10/06).
163.
Haute Autorité de Santé（フランス高等保健機構）. BEYFORTUS (nirsévimab) - Virus
respiratoire syncytial（フランス語より機械翻訳：BEYFORTUS (nirsevimab) - Respiratory syncytial
virus）. 2024/11/20. https://www.has-sante.fr/jcms/p_3556743/fr/beyfortus-nirsevimab-virus-respiratoiresyncytial (accessed 2025/10/06).
164.
Robert Koch Institut. Empfehlung zur RSV-Prophylaxe, Zielgruppe（ドイツ語より機械翻訳：
Recommendation for RSV prophylaxis, target group）. 2025/05/09.
https://www.rki.de/SharedDocs/FAQs/DE/Impfen/RSVProphylaxe/Empfehlung/FAQ_Liste_Empfehlung.html#entry_16918894 (accessed 2025/10/06).
165.
Robert Koch Institut. Epidemiologisches Bulletin - Recommendations by the Standing
Committee on Vaccination (STIKO) at the Robert Koch Institute – 2025. 2025/02/04.
https://www.rki.de/EN/Topics/Infectious-diseases/Immunisation/STIKO/STIKOrecommendations/Downloads/04_25_english.pdf (accessed 2025/10/06).
166.
Korea Ministry of Food and Drug Safety. 베이포투스주(니르세비맙)（韓国語より機械翻訳：
Beyfortus(nirsevimab)）. 2024/04/30. https://nedrug.mfds.go.kr/searchDrug (accessed 2025/10/06).
54